NYSE: BTI$ 51.14(0.768)
Reynolds champions Tobacco Harm Reduction (THR) in an array of ways, including product development and science, regulatory engagement with the Food and Drug Administration (FDA) and external engagement with interested stakeholders.
THR is an evidence-based public health strategy intended to reduce the health impact associated with using combustible tobacco products.
Reynolds and TruAge spotlight industry innovation in underage access prevention. In a recent episode of CSP’s At Your Convenience podcast, Kara Calderon, Head of Underage Access Prevention at Reynolds, and Stephanie Sikorski, CEO of TruAge, spoke about the collaborative efforts to prevent underage access to tobacco and nicotine products. The conversation highlighted … Continued
At the Reynolds American organization, we believe science should be more than a set of data points—it should also lead to meaningful change. That’s why our commitment to Tobacco Harm Reduction (THR) is grounded in science, transparency, and real-world evidence. Through THR, we aim to create A Better Tomorrow™ by Building a Smokeless World—one … Continued
Learn how the global BAT Group aims to reach 50 million adult consumers of smokeless products. The global BAT organization has a mission to create A Better Tomorrow by Building a Smokeless World and aims to reach 50 million adult consumers of its smokeless products globally by 2030. In the video above, … Continued
THR encourages adult smokers uninterested in quitting tobacco altogether to consider using an innovative, alternative nicotine product that may present less risk, like vapor, tobacco heating, oral nicotine and smokeless products.
The best choice any adult smoker can make will always be quitting tobacco products completely.
Even with this in mind, all adult tobacco users deserve to understand their alternative options, from combustible to non-combustible. Because of this, we are working to reduce the health impact of our business by offering adult consumers a greater choice of enjoyable and potentially reduced-risk*† products compared to cigarettes.
*Based on the weight of evidence and assuming a complete transition from cigarette smoking. These products are not risk-free and are addictive.
† Our Vapor product Vuse (including Alto, Solo, Ciro and Vibe) and certain products including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
Non-combustible tobacco products and moist products offer an alternative to combustible tobacco products. Nicotine pouches, Heated Products, and vapor products all present potentially lower levels of risk than combustible tobacco products. Adults who do not want to quit tobacco products altogether may instead opt to consume potentially reduced-risk products like these.